When I first started doing DD on ALEAF in early 2019 I came across this article from Angel Publications. ?
Some good info and still relevant today.
Remember some of the stocks mentioned in the article had huge runs but today, as most cannabis sector, these companies are trading way off their highs earlier in the year. Still a good read:
Introducing Aleafia, Inc. (TSX-V: ALEF) (OTCBB: ALEAF)
Aleafia, Inc. runs the Canabo Meidcal Clinic, which is Canada’s largest network of medical cannabis clinics, with 22 locations across the country.
What makes these clinics so unique is that they have the ability to cultivate certain cannabis strains to meet the specific needs of their more than 50,000 patients (and growing).
Thanks to the company’s research database, which contains more than 5 million data points, Aleafia’s physicians can make treatment recommendations proven effective through historical data, creating a faster route to patient relief and satisfaction with strains for specific medical conditions available to patients when required.
This kind of system is incredibly important in terms of treating patients with opioid addictions. The database is now actually being deployed to establish the scientific case for medical cannabis to replace opioids. In fact, Aleafia is currently working with Tilray, which ponied up the cash for the company to study the effects on opioid use and quality of life in chronic pain patients when prescribed medical cannabis.
Aleafia is also vertically-integrated, boasting its own-licensed facilities.
The first is the Scugog operation in Ontario, where the company grows pesticide-free, medical-grade cannabis.
It’s a 7,000 sq. ft. state-of-the-art indoor facility. There’s also 78 acres of developable land that’s intended for a planned multi-phase expansion. There’s also a fully-funded 150,000 sq. ft expansion underway at this location.
Aleafia also has a new location in Niagara, which is fully built and is currently being retrofitted right now to achieve significant production increases and lower operating costs. Niagara will begin production in just a few months.
Here a few more things I like about Aleafia …
1.) Management is top-notch and the team is comprised of folks that have served in senior positions in government and law enforcement. In other words, they’re well-connected to the people that matter.
2.) The entire operation is easily scalable, and make no mistake, as legalization gets closer and closer to happening in the US, Aleafia is setting up shop here. It looks like they’ll be focusing primarily on states that have high opioid addiction rates.
3.) Strong financial position. The company is sitting on $30 million in cash on hand. It has plenty of capital to continue its expansion in a strategic and sustainable manner.
4.) The company has zero debt and does $5M in revenue just from its clinics.
5.) The person who’s working with MariMed – and clued me in on MariMed – is also working with Aleafia. This guy has a knack for picking winners. We’re up more than 273% on MariMed to date. And honestly, I think we could see even bigger gains with Aleafia.
